FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:1807-1812 December 18, 1997 Number 25 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Trevathan, E. PubMed Citation

ABSTRACT

Background The Lennox–Gastaut syndrome, a severe form of epilepsy that usually begins in early childhood, is difficult to treat. Dose-related drug toxicity is common.

Methods We conducted a double-blind, placebo-controlled trial of the antiepileptic drug lamotrigine in patients with the Lennox–Gastaut syndrome. Eligible patients had more than one type of predominantly generalized seizure, including tonic–clonic, atonic, tonic, and major myoclonic, and had seizures on average at least every other day. After a 4-week base-line period in which all participants received placebo, we randomly assigned 169 patients (age range, 3 to 25 years) to 16 weeks of lamotrigine (n = 79) or placebo (n = 90) in addition to their other antiepileptic drugs.

Results The median frequency of all major seizures changed from base-line levels of 16.4 and 13.5 per week in the lamotrigine and placebo groups, respectively, to 9.9 and 14.2 per week after 16 weeks of treatment (P = 0.002). Thirty-three percent of the patients in the lamotrigine group and 16 percent of those in the placebo group had a reduction of at least 50 percent in the frequency of seizures (P = 0.01). There were no significant differences between groups in the incidence of adverse events, except for colds or viral illnesses, which were more common in the lamotrigine group (P = 0.05).

Conclusions Lamotrigine was an effective and well-tolerated treatment for seizures associated with the Lennox–Gastaut syndrome.

Source Information

From the American Memorial Hospital, Hôpital d'Enfants, Reims, France (J.M.); the Department of Neurology, Comprehensive Epilepsy Center, University of Kentucky College of Medicine, Lexington (E.T.); the Pediatric Clinic, Central County Hospital Ryhov, Jonkoping, Sweden (J.F.V.A.); Infantil Virgen del Rocio Hospital, Seville, Spain (M.N.B.); Central Nervous System Clinical Research, Glaxo Wellcome Research and Development, Greenford, Middlesex, United Kingdom (E.L.M.); and Central Nervous System Clinical Research, Glaxo Wellcome Research and Development, Research Triangle Park, N.C. (P.M.).

Address reprint requests to Dr. Trevathan at the Comprehensive Epilepsy Center, University of Kentucky College of Medicine, Kentucky Clinic L445, Lexington, KY 40536-0284.

Full Text of this Article

Related Letters:

Lamotrigine for Generalized Seizures Associated with the Lennox–Gastaut Syndrome
Trevathan E., Mullens E. L., Manasco P.
Extract | Full Text  
N Engl J Med 1998; 339:851-852, Sep 17, 1998. Correspondence

This article has been cited by other articles:

• Pina-Garza, J. E., Elterman, R. D., Ayala, R., Corral, M., Mikati, M. A., Pina-Garza, M. J., Warnock, C. R., Conklin, H. S., Messenheimer, J. A. (2008). Long-term Tolerability and Efficacy of Lamotrigine in Infants 1 to 24 Months Old. J Child Neurol 23: 853-861 [Abstract]  
• Pina-Garza, J. E., Levisohn, P., Gucuyener, K., Mikati, M. A., Warnock, C. R., Conklin, H. S., Messenheimer, J. (2008). Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. Neurology 70: 2099-2108 [Abstract] [Full Text]  
• Glauser, T., Kluger, G., Sachdeo, R., Krauss, G., Perdomo, C., Arroyo, S. (2008). Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70: 1950-1958 [Abstract] [Full Text]  
• Bourgeois, B. F.D. (2007). Broader is better: The ranks of broad-spectrum antiepileptic drugs are growing. Neurology 69: 1734-1736 [Full Text]  
• Trevathan, E., Kerls, S. P., Hammer, A. E., Vuong, A., Messenheimer, J. A. (2006). Lamotrigine Adjunctive Therapy Among Children and Adolescents With Primary Generalized Tonic-Clonic Seizures. Pediatrics 118: e371-e378 [Abstract] [Full Text]  
• Chiron, C., Tonnelier, S., Rey, E., Brunet, M.-L., Tran, A., d'Athis, P., Vincent, J., Dulac, O., Pons, G. (2006). Stiripentol in Childhood Partial Epilepsy: Randomized Placebo-Controlled Trial with Enrichment and Withdrawal Design. J Child Neurol 21: 496-502 [Abstract]  
• Kim, H. L., Aldridge, J., Rho, J. M. (2005). Clinical Experience With Zonisamide Monotherapy and Adjunctive Therapy in Children With Epilepsy at a Tertiary Care Referral Center. J Child Neurol 20: 212-219 [Abstract]  
• Sankar, R. (2004). Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues. Neurology 63: S30-S39 [Abstract] [Full Text]  
• Lofton, A. L, Klein-Schwartz, W. (2004). Evaluation of Lamotrigine Toxicity Reported to Poison Centers. The Annals of Pharmacotherapy 38: 1811-1815 [Abstract] [Full Text]  
• French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., Bergen, D., Hirtz, D., Montouris, G. D., Nespeca, M., Gidal, B., Marks, W. J. Jr., Turk, W. R., Fischer, J. H., Bourgeois, B., Wilner, A., Faught, R. E. Jr., Sachdeo, R. C., Beydoun, A., Glauser, T. A. (2004). Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62: 1261-1273 [Abstract] [Full Text]  
• LaRoche, S. M., Helmers, S. L. (2004). The New Antiepileptic Drugs: Scientific Review. JAMA 291: 605-614 [Abstract] [Full Text]  
• Jarrar, R. G., Buchhalter, J. R. (2003). Therapeutics in Pediatric Epilepsy, Part 1: The New Antiepileptic Drugs and the Ketogenic Diet. Mayo Clin Proc. 78: 359-370 [Abstract]  
• Glauser, T. A. (2002). Integrating clinical trial data into clinical practice. Neurology 58: S6-S12 [Full Text]  
• Duchowny, M., Gilman, J., Messenheimer, J., Womble, G., Risner, M., Lamictal Pediatric Study Group, (2002). Long-Term Tolerability and Efficacy of Lamotrigine in Pediatric Patients With Epilepsy. J Child Neurol 17: 278-285 [Abstract]  
• Crumrine, P. K. (2002). Antiepileptic Drug Selection in Pediatric Epilepsy. J Child Neurol 17: 2S2-2S8 [Abstract]  
• Trevathan, E. (2002). Infantile Spasms and Lennox-Gastaut Syndrome. J Child Neurol 17: 2S9-2S22 [Abstract]  
• Messenheimer, J. (2002). Efficacy and Safety of Lamotrigine in Pediatric Patients. J Child Neurol 17: 2S34-2S42 [Abstract]  
• Crumrine, P. K. (2002). Lennox-Gastaut Syndrome. J Child Neurol 17: S70-S75 [Abstract]  
• Noviasky, J. A., Porsteinsson, A. P., Lee, Y. H. (2001). Second Generation Anticonvulsant Medications: Their Use in Children. The Journal of School Nursing 17: 103-111 [Abstract] [Full Text]  
• (2001). Managing childhood epilepsy. DTB 39: 12-16 [Abstract] [Full Text]  
• MARSON, A G, CHADWICK, D W (2001). New drug treatments for epilepsy. J. Neurol. Neurosurg. Psychiatry 70: 143-147 [Full Text]  
• Glauser, T. A. (2000). Topiramate in the Catastrophic Epilepsies of Childhood. J Child Neurol 15: S14-S21 [Abstract]  
• Tatum, W. O. IV, Galvez, R., Benbadis, S., Carrazana, E. (2000). New Antiepileptic Drugs: Into the New Millennium. Arch Fam Med 9: 1135-1141 [Abstract] [Full Text]  
• Parmeggiani, L., Belmonte, A., Rita Ferrari, A., Perucca, E., Guerrini, R. (2000). Add-On Lamotrigine Treatment in Children and Young Adults With Severe Partial Epilepsy: An Open, Prospective, Long-Term Study. J Child Neurol 15: 671-674 [Abstract]  
• Hosain, S., Nikalov, B., Harden, C., Li, M., Fraser, R., Labar, D. (2000). Vagus Nerve Stimulation Treatment for Lennox-Gastaut Syndrome. J Child Neurol 15: 509-512 [Abstract]  
• Duchowny, M., Pellock, J. M., Graf, W. D., Billard, C., Gilman, J., Casale, E., Womble, G., Risner, M., Manasco, P. (1999). A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology 53: 1724-1724 [Abstract] [Full Text]  
• Pellock, J. M. (1999). Managing Pediatric Epilepsy Syndromes With New Antiepileptic Drugs. Pediatrics 104: 1106-1116 [Abstract] [Full Text]  
• Sachdeo, R. C., Glauser, T. A., Ritter, F., Reife, R., Lim, P., Pledger, G. (1999). A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 52: 1882-1882 [Abstract] [Full Text]  
• Devinsky, O. (1999). Patients with Refractory Seizures. NEJM 340: 1565-1570 [Full Text]  
• Vossler, D. G., Jung Kyo Lee, , Tae Sung Ko, (1999). Treatment of Seizures in Subcortical Laminar Heterotopia With Corpus Callosotomy and Lamotrigine. J Child Neurol 14: 282-288 [Abstract]  
• French, J., Smith, M., Faught, E., Brown, L. (1999). Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 52: 1540-1540 [Full Text]  
• Lombroso, C. T. (1999). Lamotrigine-induced tourettism. Neurology 52: 1191-1191 [Abstract] [Full Text]  
• Bare, M. A., Glauser, T. A., Strawsburg, R. H. (1998). Need for Electroencephalogram Video Confirmation of Atypical Absence Seizures in Children With Lennox-Gastaut Syndrome. J Child Neurol 13: 498-500 [Abstract]  
• Trevathan, E., Mullens, E. L., Manasco, P. (1998). Lamotrigine for Generalized Seizures Associated with the Lennox-Gastaut Syndrome. NEJM 339: 851-852 [Full Text]  
• Bourgeois, B. F. D. (1998). New Antiepileptic Drugs. Arch Neurol 55: 1181-1183 [Abstract] [Full Text]  
• Herman, S. T., Pedley, T. A. (1998). New Options for the Treatment of Epilepsy. JAMA 280: 693-694 [Full Text]  
• Chadwick, D. (1998). Do New Antiepileptic Drugs Justify Their Expense?. Arch Neurol 55: 1140-1142 [Full Text]